SMS Pharmaceuticals Stock Price Analysis and Quick Research Report. Is SMS Pharmaceuticals an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse SMS Pharmaceuticals. 

• PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). SMS Pharmaceuticals has a PE ratio of 40.0642478206393 which is high and comparatively overvalued.

• Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. SMS Pharmaceuticals has ROA of 4.9487% which is a bad sign for future performance. (Higher values are always desirable.)

• Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. SMS Pharmaceuticals has a Current ratio of 1.5831.

• Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. SMS Pharmaceuticals has a ROE of 9.5322%. (Higher is better)

• Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. SMS Pharmaceuticals has a Debt to Equity ratio of 0.517 which means that the company has low proportion of debt in its capital.

• Sales growth: SMS Pharmaceuticals has reported revenue growth of 35.8608% which is fair in relation to its growth and performance. 

• Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of SMS Pharmaceuticals for the current financial year is 16.493646789049%.

• Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for SMS Pharmaceuticals is Rs 0.4 and the yield is 0.1342%.

• Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of SMS Pharmaceuticals is Rs 7.5022. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of SMS Pharmaceuticals in Ticker for free. Also, one can get the intrinsic value of SMS Pharmaceuticals by using Valuation Calculators, which are available with a Finology ONE subscription. 

SMS Pharmaceuticals FAQs

Q1. What is SMS Pharmaceuticals share price today?
Ans: The current share price of SMS Pharmaceuticals is Rs 300.57.

Q2. What is the market capitalisation of SMS Pharmaceuticals?
Ans: SMS Pharmaceuticals has a market capitalisation of Rs 2814.89906571 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of SMS Pharmaceuticals?
Ans: The PE ratio of SMS Pharmaceuticals is 40.0642478206393 and the P/B ratio of SMS Pharmaceuticals is 3.85462286714587, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of SMS Pharmaceuticals share?
Ans: The 52-week high share price of SMS Pharmaceuticals is Rs 398, and the 52-week low share price of SMS Pharmaceuticals is Rs 176.05.

Q5. Does SMS Pharmaceuticals pay dividends?
Ans: Currently, SMS Pharmaceuticals pays dividends. Dividend yield of SMS Pharmaceuticals is around 0.1342%.

Q6. What are the face value and book value of SMS Pharmaceuticals shares?
Ans: The face value of SMS Pharmaceuticals shares is Rs 1, while the book value per share of SMS Pharmaceuticals is around Rs 77.9765. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of SMS Pharmaceuticals?
Ans: SMS Pharmaceuticals has a total debt of Rs 280.1787 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of SMS Pharmaceuticals?
Ans: The ROE of SMS Pharmaceuticals is 9.5322% and ROCE of SMS Pharmaceuticals is 11.253%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is SMS Pharmaceuticals a good buy for the long term?
Ans: The SMS Pharmaceuticals long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is SMS Pharmaceuticals undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the SMS Pharmaceuticals appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check SMS Pharmaceuticals’s financials?
Ans: You can review SMS Pharmaceuticals’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.